13F

Stock

Crispr Therapeutics Ag

CRSP · held by 10 managers

Reported value

$20.7M

Holders

10

+2 new · −0 exited

Holders’ est. mark

$1.58M

Price effect on 6 books still in the name

Largest holder

$18.5M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC380.6K$18.5M$1.31MAdded$15.5M
NWAM LLC18.3K$1.03MHeld
Norris Financial Group, LLC9.72K$473K$141.4KAdded$143.7K
Sanctuary Advisors, LLC9.09K$442.2K$126.1KAdded$148.5K
INDEPENDENT FINANCIAL GROUP, LLC4.54K$220.6KNew
ELEVATION POINT WEALTH PARTNERS, LLC300$14.6KNew
Medallion Wealth Advisors, LLC124$6.01K$1.91KAdded$1.91K
DANSKE BANK A/S100$4.86K$1.46KAdded$1.46K
Essential Partners LLC71$3.45KHeld
Nalls Sherbakoff Group, LLC3$146$44Cut−$92

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.